Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1561-1568

  Van Der Velden, L B J ^a   Tromp, M ^a   Bleeker Rovers, C P ^a   Hulscher, M ^a   Kullberg, B J ^a   Mouton, J W ^a   Sturm, P D J ^a   Pickkers, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; FLUCLOXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; ASPIRATION PNEUMONIA; BACTERIUM ISOLATION; CANDIDA; CELLULITIS; CHOLANGITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; EMERGENCY WARD; ENTEROCOCCUS FAECALIS; ERYSIPELAS; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; IN VITRO STUDY; LISTERIOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MICROBIOLOGICAL EXAMINATION; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RETROSPECTIVE STUDY; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTION; AGED; BACTERIUM; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 84865599066     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1478-5     Document Type: Article

References (20)

1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589-1596
2. Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48(5):583-590, 590.e1
3. Bodí M, Rodríguez A, Solé-Violán J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators (2005) Antibiotic prescription for communityacquired pneumonia in the intensive care unit: Impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 41(12):1709-1716
4. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM; Committee Surviving Sepsis Campaign Management Guidelines (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3):858-873
5. Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS (2010) Guidelineconcordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 32(2):293-299
6. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045-1053
7. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244(5):379-386
8. Galayduyk N, Colodner R, Chazan B, Flatau E, Lavi I, Raz R (2008) Adherence to guidelines on empiric use of antibiotics in the emergency room. Infection 36(5):408-414
9. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN (2009) Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: Playing by the rules. Arch Intern Med 169(16):1525-1531
10. Mortensen EM, Restrepo M, Anzueto A, Pugh J (2004) Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 117 (10):726-731
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G; SCCM/ESICM/ACCP/ ATS/SIS (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250-1256
12. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, LammW, Clark C,MacFarquhar J,WaltonAL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791-797
13. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58(5):377-382
14. McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS (2005) Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165(3):308-313
15. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136(11):834-844
16. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162(2 Pt 1):505-511
17. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr (2004) Trends in antimicrobial drug development: Implications for the future. Clin Infect Dis 38(9):1279-1286
18. Mol PG, Wieringa JE, Nannanpanday PV, Gans RO, Degener JE, Laseur M, Haaijer-Ruskamp FM (2005) Improving compliance with hospital antibiotic guidelines: A time-series intervention analysis. J Antimicrob Chemother 55(4):550-557
19. Mol PG, Rutten WJ, Gans RO, Degener JE, Haaijer-Ruskamp FM (2004) Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis 10(3):522-525
20. Schouten JA, Hulscher ME, Natsch S, Kullberg BJ, van der Meer JW, Grol RP (2007) Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: A qualitative study. Qual Saf Health Care 16(2):143-149